Physician profile
Apai Polyudhapoom
NPI 1093885915
$2,077.85
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $205 · 2020: $285 · 2021: $602 · 2022: $422 · 2023: $508 · 2024: $56.28.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $564.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $564.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $252.70 | 2019-2023 | Evenity, Prolia |
| Pfizer INC. | $211.40 | 2019-2024 | |
| Gilead Sciences, INC. | $190.93 | 2019-2023 | Epclusa |
| Abbvie INC. | $185.94 | 2019-2023 | |
| Astrazeneca Pharmaceuticals Lp | $180.01 | 2019-2024 | Breztri |
| Merck Sharp & Dohme LLC | $132.39 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $130.92 | 2021 | |
| Lilly USA, LLC | $126.17 | 2021-2023 | Mounjaro |
| Biohaven Pharmaceutical Holding Company Ltd. | $111.00 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $110.58 | 2022-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $97.11 | 2020-2022 | |
| Glaxosmithkline, LLC. | $87.20 | 2021-2023 | Bexsero |
| Dexcom, INC. | $46.21 | 2023 | Dexcom G6 Transmitter |
| Xeris Pharmaceuticals, INC. | $41.53 | 2022-2023 | Gvoke Hypopen |
| Vbi Vaccine (Delaware) INC. | $38.78 | 2023 | Prehevbrio |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dynavax Technologies Corporation | $33.54 | 2021-2022 | |
| Horizon Therapeutics Plc | $22.29 | 2023 | Krystexxa |
| Janssen Pharmaceuticals, INC | $20.77 | 2021 | |
| Exact Sciences Corporation | $19.10 | 2023 | Cologuard Collection Kit |
| Alkermes, INC. | $15.34 | 2020 | |
| Amarin Pharma, INC. | $12.15 | 2019 | |
| Philips North America LLC | $11.79 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Apai Polyudhapoom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.